GSK vs HLNE · P/E 13, $103.31B cap vs P/E 15, rev $759.0M
GlaxoSmithKline PLC ADR (GSK) versus Hamilton Lane Inc (HLNE) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Hamilton Lane Inc (HLNE) is a asset management company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported HLNE revenue for 2026-03-31 was $759.0M. Net income was $249.2M. Revenue was up 6.5% from 2025-03-31 to 2026-03-31. HLNE currently screens at market cap $4.84B and trailing P/E 14.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. HLNE currently screens at market cap $4.84B and trailing P/E 14.7.
Not investment advice. Open the GSK and HLNE stock pages for the full models.
Not investment advice.